drugset / Trial / NCT04426643

Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells

NCT04426643

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Treatment of patients with urinary incontinence after prostatectomy using injection of autologous adipose-derived mesenchymal stem cells mixed with collagen gel

Timeline

Start
2020-08-01
Primary completion
2021-02-20
Completion
2021-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous adipose-derived mesenchymal stem cells Cell therapy 2e+07 cells Other

Indications

No indication recorded.